The Synergism Or Long Duration (SOLD) Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of the study is to compare disease-free survival (DFS) of women treated with concomitant trastuzumab plus docetaxel followed by FEC to that of the women treated with the same regimen followed by single-agent trastuzumab to complete one year of trastuzumab administration as adjuvant treatments of early HER2-positive breast cancer.
Epistemonikos ID: f141d94dda16de6855b0cccf9db68d17c7145c3b
First added on: May 04, 2024